Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0067 | 0.9 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.9 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |